Trending

pancreatic cancer cells

Researchers Identify Familial Pancreatic Cancer Gene

Researchers at Harvard Medical School have sequenced the genomes of a family in which multiple members had pancreatic cancer and found a mutation in a gene linked to the RAS signaling pathway that controls cell growth and death. Researchers argue that the into how RABL3 impacts the signaling pathway could lead to novel targeted therapy.

Brigham and Women’s Hospital Opens Preventive Genomics Clinic

Brigham and Women’s Hospital has launched the Preventive Genomics Clinic, a facility designed to provide comprehensive DNA sequencing, interpretation and reporting of disease-associated genes. The...
Mouth Microbiome

Researchers Find Greater Than Expected Diversity in Human Microbiome Genes

Scientists have mapped the genetic diversity of microbes residing in the human gut and mouth.
Could Based Genomics Data

Q-State Biosciences and 2bPrecise Sign Precision Medicine Deal

The Q-State Biosciences and 2bPrecise partnership aims to achieve improved diagnostic yields and patient outcomes by using clinical tools to match patients with precise therapies based on their health attributes and genetic profile.
Meeting handshake

GeneCentric Therapeutics Acquires Select ImmunoGenomics for Biomarker Discovery

GeneCentric Therapeutics has broadened its tool set for subtyping cancer patients by acquiring Select ImmunoGenomics. The combined company now boasts a large, integrated set of RNA-based solutions for identifying the right patients for specific oncology drugs and improving response rates, treatment durability, and ultimately patient outcomes.
Human microbiome, conceptual illustration

Tumor Microbiome Linked to Survival in Pancreatic Cancer Patients

Fecal transplants from long-term survivors of pancreatic cancer patients to newly diagnosed ones may one day save lives.
The NIH’s All of Us Research Program has awarded a total $28.6 million to establish three genome centers nationwide. In addition to producing genome data for researchers

One Year After Launch, NIH’s All of Us Hits Key Milestones

As big genomics projects take off around the world, the U.S.’s initiative has made a fast start, enrolling 175,000 participants in the All of...
GNS and Swedish Cancer Institute launch collaboration aimed at advancing the use of precision medicine in care for breast cancer patients. [Source: © Arto/Fotolia.com]

Methylation Implicated in Aspirin Benefit for Breast Cancer Patients

Prior studies have suggested that women who take aspirin before being diagnosed with breast cancer (BC) may live longer than women who haven’t historically...
DNA research concept DNA barcodes for biomedical research  mitochondrial DNA  Prostate cancer DNA test

8 Companion Diagnostic Developers Making a Mark

If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
DNA strands on unaligned genome sequence.

Seven Bridges Expands into Serbia

Seven Bridges, a biomedical software and data analytics company, plans to expand operations into Novi Sad, Serbia, to meet growing demand for its products and services.
Electronic Health Record

Irish Researchers Integrate Epilepsy Genomics into Electronic Patient Records

Researchers in Ireland are one step closer to offering seamless personalized care to epilepsy patients nationwide, reporting that they have developed a genomics module...
Depressed woman with head in hands

UnitedHealthcare To Cover Genetic Testing for Precision Medicine in Depression, Anxiety

The nation’s largest private health insurer, UnitedHealthcare, announced August 1 that it will cover testing that will allow physicians to match their patients to...
Biocept Inc Logo

Multi-Gene Liquid Biopsy Breast Cancer Panel

Liquid biopsy test provider Biocept has announced Target Selector NGS Breast Panel, a multi-gene liquid biopsy panel specifically developed for breast cancer. The Target...

Next-Generation Analytics for Cancer Treatment Decision Making

Oncology Analytics announced the release of Oncology Insights, a next-generation analytics software solution that delivers current, relevant, and structured oncology data, supported by expert...
Diabetes mellitus metabolic disease signs and symptoms concept, 3D rendering

Actionable Type 2 Diabetes Risks Uncovered

More than 67 actionable clinical discoveries were made through deep longitudinal genomic analysis by a group led by Michael Snyder, MD, chair of the...
elderly man with head breaking apart

Feasibility Study Finds Informative Digital Biomarkers of Dementia

Combining wearable devices, handheld devices and digital apps lets researchers tell the difference between people with early dementia and those without it.
DNA and money

Gene Therapy Firm Renovacor Closes $11 Million Series A Financing

Proceeds from the Renovacor financing will help advance the company’s first-of-its-kind gene replacement therapy through IND filing, in preparation to initiate clinical trials in dilated cardiomyopathy (DCM) patients with mutations in the BAG3 gene.
Extending a collaboration launched last year

Celsee, IncellDx Sign Lung Cancer CTC PD-L1 Agreement

The companies will co-commercialize their respective single-cell technologies for CTCs and PD-L1 expression following positive study results
A three-protein biomarker panel has been established that is able to screen urine samples for signs of early-stage pancreatic cancer. [iStock/© David Marchal]

Pancreatic Cancer Patients with BRCA1/BRCA2 Respond to PARP Inhibitor

In the first Phase III trial ever to test maintenance treatment with a PARP inhibitor in pancreatic cancer, patients with germline BRCA1 or BRCA2...
Source: NIH

The Punctuated Equilibrium of Pancreatic Cancer

The new findings from the Ontario Institute for Cancer Research provide important insights into how pancreatic cancer develops and spreads.
Source: freestylephoto/Getty Images

20 Molecular Diagnostics Companies to Watch

Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
Prostate cancer, illustration

Myriad to Pursue mCRPC Approval for BRACAnalysis CDx

Myriad Genetics said today it will pursue FDA authorization of its BRACAnalysis CDx test as a companion diagnostic for the AstraZeneca/Merck & Co. co-marketed...

Helix Partners with AdventHealth on Screening for FH-Linked Genes

Personal genomics company Helix is partnering with the Central Florida Division of healthcare provider AdventHealth in an ambitious study that will screen participants for...
Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
Scroll Up